These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2961307)

  • 1. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
    Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of 5'-deoxy-5-fluorouridine (5'-DFUR) administration before surgery for advanced gastric and colonic cancers--activity of pyrimidine nucleoside phosphorylase (PyNPase) and serum immunosuppressive acidic protein (IAP)].
    Murakami N; Hirano M; Saito H; Nagao S; Arano Y; Kikuchi T; Ishikawa N; Kurokawa M; Kitsukawa H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1959-66. PubMed ID: 8978804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)].
    Yamaguchi A; Maeda A; Hachisuka K; Yura J; Honda K; Honda H; Yoshizaki S; Tsuruga N; Nakazato H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):621-6. PubMed ID: 8154887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study.
    Ahn MJ; Han DS; Sohn JH; Jeon YC; Jun DW; Choi NW; Park HK; Baik HK; Lee HG; Nam YS; Choi IY
    J Korean Med Sci; 1998 Dec; 13(6):612-6. PubMed ID: 9886169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
    Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1029-32. PubMed ID: 8210253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
    Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR) for solid tumors.
    Shimizu E; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Fujita J; Nomori H; Hoshi A
    Jpn J Clin Oncol; 1984 Dec; 14(4):679-83. PubMed ID: 6240546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer].
    Kobayashi T; Kimura T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1521-6. PubMed ID: 11015996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakao I; Saito T; Kimura K; Wakui A; Yokoyama M; Kanamaru R; Furue H; Komita T; Ohta K; Murakami M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2037-43. PubMed ID: 2932058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
    Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
    Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
    Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer.
    Yoshino S; Furuya T; Shimizu R; Ozasa H; Nishimura T; Fukuda S; Kawaoka T; Hazama S; Oka M
    Anticancer Res; 2013 Jun; 33(6):2629-33. PubMed ID: 23749919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2977-82. PubMed ID: 2959207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological study of 5'-DFUR oral administration and the clinical responses against gastrointestinal carcinoma].
    Matsuoka H; Seo Y; Ohshiro T; Adachi E; Nagamine S; Miyazaki N; Shiromizu A; Baba H; Kounoe S; Saito T
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):383-8. PubMed ID: 7880109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Randomized controlled study of sequential methotrexate and 5-fluorouracil therapy with or without 5'-deoxy-5-fluorouridine against advanced gastrointestinal cancer. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
    Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1187-92. PubMed ID: 8031160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.